4D Molecular Therapeutics
FDMT
FDMT
151 hedge funds and large institutions have $471M invested in 4D Molecular Therapeutics in 2026 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 39 increasing their positions, 49 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
20% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 49
31% less call options, than puts
Call options by funds: $1.06M | Put options by funds: $1.53M
Holders
151
Holding in Top 10
–
Calls
$1.06M
Puts
$1.53M
Top Buyers
| 1 | +$11.3M | |
| 2 | +$5.32M | |
| 3 | +$3.51M | |
| 4 |
PBM
Propel Bio Management
Los Angeles,
California
|
+$3.31M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.22M |
Top Sellers
| 1 | -$15.2M | |
| 2 | -$11.5M | |
| 3 | -$5.25M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$3.57M |
| 5 |
Morgan Stanley
New York
|
-$2.85M |
